Vaginitis in a gynecologic practice in Israel: causes and risk factors

Isr Med Assoc J. 2003 Sep;5(9):629-32.

Abstract

Background: Vaginal symptoms are a leading reason for a patient to visit her gynecologist. Little is known about the prevalence of the different causes of vaginitis and the risk factors for this entity in Israel.

Objective: To determine the prevalence of the main forms of vaginitis: vulvovaginal candidiasis, bacterial vaginosis, and trichomoniasis, in a gynecologic practice in Israel.

Methods: We evaluated 208 patients presenting with vaginal symptoms to a gynecologic clinic; 100 asymptomatic women who attended the clinic for routine check-up served as controls. Demographic, medical and gynecologic histories were obtained, and a pelvic examination was performed in all patients. Vaginal specimens were tested for pH and amine reaction, smeared for Gram-staining and cultured for yeasts and Trichomonas vaginalis. Bacterial vaginitis was diagnosed using the Nugent scoring system. Candida infection was diagnosed by microscopic examination and by culture.

Results: Candida spp. was the most common pathogen, documented by microscopy and culture in 35.5% of symptomatic women and 15% of asymptomatic controls (P < 0.001). Detection by culture only (negative microscopy) was documented in 18.7% of symptomatic patients and 15% of controls (P = 0.5). Bacterial vaginosis (Nugent score > or = 7) was diagnosed in 23.5% of patients and 13% of controls (P = 0.04). Trichomoniasis was present in 8.1% of symptomatic women and 4% of controls (P = 0.1). The main risk factors were antibiotic use for candidiasis and lack of use of oral contraception and condom use for trichomoniasis.

Conclusion: Candida was by far the most common pathogen detected in our population. A statistically significant difference between patients and controls was noted for the prevalence of microscopically diagnosed candidiasis and bacterial vaginosis.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Age Distribution
  • Ambulatory Care Facilities / statistics & numerical data*
  • Anti-Bacterial Agents / therapeutic use
  • Candida / isolation & purification
  • Candidiasis, Vulvovaginal / epidemiology
  • Causality
  • Chlamydia Infections / epidemiology
  • Contraception Behavior / statistics & numerical data
  • Female
  • Gonorrhea / epidemiology
  • Gynecology* / statistics & numerical data*
  • Humans
  • Israel / epidemiology
  • Prevalence
  • Reference Values
  • Risk Factors
  • Trichomonas Vaginitis / epidemiology
  • Vagina / microbiology
  • Vaginitis / epidemiology*
  • Vaginosis, Bacterial / epidemiology

Substances

  • Anti-Bacterial Agents